<DOC>
	<DOC>NCT01280578</DOC>
	<brief_summary>A prospective, single arm, multicenter clinical registry evaluating the change in migraine headaches in migraine with aura patients who undergo patent foramen ovale (PFO) closure with the Coherex FlatStent™ EF PFO Closure System.</brief_summary>
	<brief_title>The Coherex FlatStent™ EF PFO Migraine Registry</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<criteria>Major Age 1865 males and non pregnant females History of refractory migraine Documented PFO Major Known allergy to aspirin or nickel. Medication Overuse Headache Body mass index &gt; 40. Recent Botulinum neurotoxin type A treatment Other known structural heart disease, coronary artery disease, atrial fibrillation PFO morphology not suitable for FlatStent EF Patients who have had a stroke within the past two months Posttraumatic headache. Patients with diagnosed hypercoagulable states that require chronic treatment with warfarin.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Migraine</keyword>
</DOC>